The wellness industry's progesterone problem

Progesterone cream is one of the most confidently marketed hormonal products in the wellness space — sold with claims ranging from PMS relief to perimenopause support to "balancing estrogen dominance." Some of these claims have a kernel of science behind them. Others don't hold up under scrutiny.

The core issue is absorption. Transdermal progesterone from OTC cream is absorbed through the skin, but how much actually enters systemic circulation varies enormously between individuals, products, and application sites. Studies report ranges of 10% to 80%. That's not a dosing uncertainty you can work around — it means you may be getting a pharmacological dose or almost nothing, with no reliable way to tell without testing.

10–80%
Reported absorption range for OTC topical progesterone creams across published studies. The same labeled dose can produce dramatically different systemic levels depending on formulation, skin site, and individual factors
No uterine protection
Multiple studies confirm that standard OTC progesterone cream does not reliably produce the serum levels needed to protect the uterine lining in women using estrogen — making it unsafe as a standalone uterine protectant
Rx needed
Oral micronized progesterone (Prometrium, 100–200 mg) produces predictable serum levels, has robust RCT data, and is the form used in all clinical trials showing progesterone's safer profile versus synthetic progestins

Why the endometrial protection gap matters

If you have a uterus and are using estrogen — for perimenopause symptoms, HRT, or any other reason — you need adequate progesterone to protect the uterine lining from estrogen-driven overgrowth. Unopposed estrogen is associated with endometrial hyperplasia and, over time, increased risk of endometrial cancer. Progesterone prevents this by inducing the secretory changes that shed or stabilize the lining.

The problem: research has consistently shown that standard OTC cream doses do not produce the serum progesterone levels required to create this protective endometrial response. A 2003 study by Burry and colleagues measured endometrial biopsies in women using OTC progesterone cream alongside estrogen — and found inadequate secretory transformation in the lining. This is not a theoretical risk. It's a documented, measurable clinical gap.

Key Research

A 2014 PMC review of progesterone for symptomatic perimenopause treatment (Greenblatt and Asch) noted that while oral micronized progesterone is "safe, appropriate, and effective" for perimenopausal women, transdermal cream is "generally less effective than capsules" and does not reliably achieve the serum levels needed for endometrial protection. The Burry et al. 2003 study specifically found inadequate endometrial secretory transformation in women using OTC cream with estrogen. Both the North American Menopause Society and major gynecological bodies recommend against relying on OTC cream for uterine protection in women using estrogen.

The nuance: natural progesterone (including bioidentical oral micronized) has a genuinely better safety profile than synthetic progestins for certain risks — specifically, it does not appear to increase breast cancer risk the way medroxyprogesterone acetate (found in older combined HRT formulations) does, and it has a more favorable cardiovascular profile. But this advantage only applies to the prescription oral form, where dosing is reliable. You can't claim this benefit from OTC cream when absorption is unpredictable.

When OTC cream might help — and when it won't

For mild PMS symptoms, including sleep disruption and mood changes in the luteal phase, some women do report benefit from low-dose topical progesterone. The evidence here is limited but not zero. A 2005 study using 2% progesterone cream found modest improvements in menopausal symptoms. If you're not using estrogen and your goal is mild symptom support rather than medical progesterone replacement, the risk profile is lower.

Where OTC cream is not appropriate: as a substitute for prescription progesterone in HRT, as a treatment for PCOS-related anovulation (where cyclic oral micronized progesterone has actual trial data), or as endometrial protection for women using any form of estrogen therapy. For those indications, oral micronized progesterone requires a prescription and produces evidence-backed results that cream cannot reliably replicate.

What to tell your doctor

👩‍⚕️

If you have an intact uterus and are using any form of estrogen — topical, oral, patch, or vaginal — you need an adequate form of progestogen to protect your uterine lining. OTC progesterone cream is not reliably sufficient for this purpose. Discuss prescription oral micronized progesterone with your gynecologist or menopause specialist.

Medical Disclaimer: This article is for informational and educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

Sources

  1. Burry KA, et al. Percutaneous absorption of progesterone in postmenopausal women treated with transdermal estrogen. Am J Obstet Gynecol. 1999;180(6):1504-11.
  2. du Toit T, Louw R, Swart AC. Progesterone cream absorption through the skin. Eur J Endocrinol. 2005;152(6):863-868.
  3. Greenblatt RB, Asch RH. Progesterone for Symptomatic Perimenopause Treatment. PMC. 2014. PMC3987489.
  4. Leonetti HB, et al. Transdermal progesterone cream for vasomotor symptoms and postmenopausal bone loss. Obstet Gynecol. 1999;94(2):225-8.
  5. Kaunitz AM. Transdermal progesterone cream for menopausal women: A promising therapy or mirage? Menopause. 1999;6(3):167-9.